# US 2002/0165365 A1 · Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0165365 A1
- Document ID: US20020165365A1
- Status: Published application
- Kind: A1
- Application number: 10/120,084
- Filed: 2002-04-10
- Published: 2002-11-07
- Earliest claimed: 2001-04-24
- Assignees: Artzyme Biotech Corporation
- Inventors: Junghun Suh; Sang Jun Son; Jung Bae Song; Chang Eun Yoo; Chul-Seung Jeung; Joongwon Jeon; In Seok Hong
- Web page: https://patentgrep.com/patent/US20020165365A1

## CPC

- C07D 239/47: One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 239/56: One oxygen atom and one sulfur atom
- C07D 257/02: not condensed with other rings
- C07D 473/16: two nitrogen atoms
- C07D 473/18: one oxygen and one nitrogen atom, e.g. guanine
- C07D 495/04: Ortho-condensed systems
- C07K 14/003: {Peptide-nucleic acids (PNAs)}
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention relates to a synthetic catalyst of the following formula (A) which can selectively recognize and cleave a specific protein among a protein mixture, and to a method for selective cleavage of a target protein using the same: (R)(Z)n (A) in which n denotes an integer of 1 or more, R represents a material capable of selectively recognizing and binding a target protein, and Z represents a metal ion-ligand complex.

## Claims

### Claim 1

A synthetic catalyst represented by the following formula (A) which has an ability to selectively cleave a target protein:
(R)(Z)n (A)
in which
n denotes an integer of 1 or more,
R represents a material capable of selectively recognizing and binding a target protein, and
Z represents a metal ion-ligand complex.

### Claim 2 (depends on 1)

The synthetic catalyst of claim 1 wherein the ligand is cyclic or acyclic and one to four of the metal-coordinating atoms contained in the ligand are nitrogen atoms.

### Claim 3 (depends on 1, 2)

The synthetic catalyst of claim 1 or 2 wherein the skeleton of the ligand is one or more selected from the group consisting of:
22

### Claim 4 (depends on 1)

The synthetic catalyst of claim 1 wherein the metal ion is one or more selected from the group consisting of Ni(II), Cu(II), Zn(II), Pd(II), Cr(III), Fe(III), Co(III), Rh(III), Ir(III), Ru(III), Pt(IV), Zr(IV), and Hf(IV).

### Claim 5 (depends on 1)

The synthetic catalyst of claim 1 wherein R and Z are linked together through a linker.

### Claim 6 (depends on 5)

The synthetic catalyst of claim 5 wherein the linker contains a main chain, which has a backbone made of 1 to 30 atoms of boron, carbon, nitrogen, oxygen, silicon, phosphorus, and/or sulfur, belonging to functional groups such as alkyl, aryl, carbonyl, amine, ether, hydroxy, silyl, sulfhydryl, and/or thioether groups as well as derivatives such as amides, imides, esters, and/or thioesters.

### Claim 7 (depends on 5)

The synthetic catalyst of claim 5 wherein the linker may contain side chains, each of which has a backbone made of 1 to 30 atoms of boron, carbon, nitrogen, oxygen, silicon, phosphorus, and/or sulfur, belonging to functional groups such as alkyl, aryl, carbonyl, amine, ether, hydroxy, silyl sulfhydryl, and/or thioether groups as well as derivatives such as acids, amides, imides, esters, and/or thioesters.

### Claim 8 (depends on 1)

A method for selectively cleaving a target protein characterized by using the synthetic catalyst as defined in claim 1.
